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COMMENTARY: SIMPLE GASES AND COMPLEX SINGLE VENTRICLES 
David L. Wessel, MD 
Management of patients born with hypoplastic left 
heart syndrome or other complex single ventricle 
anatomy continues to challenge the technical skills 
of surgeons and the innovation and vigilance of 
those involved in perioperative care. Although mor- 
tality substantially improved after the introduction 
of palliative techniques for patients with single 
ventricle physiology who require complex aortic 
arch reconstruction, 1-3the national experience still 
suggests less than optimal outcomes for many pa- 
tients. 4
Postoperative management 
Common teaching has held that postoperative 
mortality and hemodynamic lability are attributable 
to myocardial dysfunction and the physiologic bur- 
den imposed by a shunt-dependent pulmonary cir- 
culation in parallel with systemic blood flow. Cur- 
rent treatment strategies have emphasized factors 
that may affect he balance between pulmonary and 
systemic blood flow. s Immediately after a Norwood 
operation pulmonary vascular resistance (PVR) may 
be transiently elevated, but soon decreases. Once 
PVR falls, treatment isaimed at raising resistance to 
blood flow through the lungs and redirecting cardiac 
output to the systemic irculation. High inspired 
concentration of oxygen, hyperventilation, alkalosis, 
systemic vasoconstriction, and anemia may exacer- 
bate pulmonary vasodilation and are avoided. Ther- 
apies designed to raise PVR and thereby direct 
aortic blood flow to the systemic irculation have 
entailed lowering the inspired oxygen fraction (Fio2) 
or allowing the arterial carbon dioxide tension 
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(Paco2) to rise. Further measures, uch as ventila- 
tion with hypoxic gas mixtures or added carbon 
dioxide, have been advocated by some centers and 
have been intermittently embraced and abandoned 
by others. Validation of the effectiveness of these 
techniques to balance the pulmonary and systemic 
circulations has been difficult. Direct measurement 
of cardiac output or pulmonary artery pressure is 
not easy in the neonate with a shunt and univen- 
tricular heart. For the ratio of pulmonary-to-sys- 
temic blood flow (Qp/Qs) to be estimated, superior 
vena cava (not right atrial) blood must be sampled 
and estimates made of pulmonary venous oxygen- 
ation. Absence of an appropriate animal model with 
direct measurement of single ventricle physiology 
has hindered progress in this field. 
Animal models 
In the August and September issues of the Jour- 
nal, two articles 6' 7 describe the use of animal mod- 
els of single ventricle physiology to test he effects of 
changing concentrations of simple gases, oxygen, 
hydrogen (pH), carbon dioxide, and nitric oxide on 
such important physiologic variables as Qp/Qs, sys- 
temic and venous oxygenation, and oxygen delivery. 
Development of these animal models provides an 
experimental basis for testing hypotheses pertinent 
to this area of congenital heart disease. 
Riordan and associates 7 describe a model using 
piglets that have undergone ligation of the pulmo- 
nary artery and disruption of the tricuspid valve 
after a balloon atrial septostomy and placement of a 
6 mm polytetrafluoroethylene graft from the aorta 
to the pulmonary artery. The pulmonary and sys- 
temic hemodynamics were measured directly in 
response to hypoxic and hyperoxic gas mixtures 
along with increased inspired carbon dioxide and 
addition of positive end-expiratory pressure. PVR 
increased as Fio 2 was progressively lowered from 1.0 
to 0.21. PVR also increased with positive end- 
expiratory pressure. Most important, the authors 
demonstrate hat systemic arterial oxygen saturation 
itself is not predictive of improved systemic blood 
flow or oxygen delivery. Mixed venous oxygen satu- 
ration interpreted in conjunction with systemic ar- 
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terial oxygen saturation is a more reliable predictor 
of Qp/Qs and optimal oxygen delivery. A Qp/Qs of 
0.7 appeared to be the ideal ratio in this model. 
Readers looking for therapeutic recipes based on 
this model will be disappointed. Surprisingly, the 
"best" Fio 2 was 0.5, not 0.21, and PVR did not rise 
substantially with inhaled carbon dioxide until the 
pH was less than 6.9. These data are not consistent 
with previously published animal work s or with 
postoperative studies in infants, in whom the pul- 
monary vasculature seems to be sensitive to modest 
changes in pH. 9 These differences probably relate to 
limitations of the model, because it is not entirely 
analogous to the neonate recovering from a Nor- 
wood operation. The model retains ome features of 
two-ventricle physiology; the right ventricle fills and 
ejects a variable volume back through the tricuspid 
valve. Complex ventricular interaction may vary 
according to the amount of tricuspid regurgitation 
and the pressure developed in the right ventricle. 
Although the shunt diameter (6 mm) is large, it does 
not result in either a substantial rise in pulmonary 
artery pressure or any significant increase in Qp/Qs 
(maximal average Qp/Qs 1.2). Furthermore, it is not 
a model that incorporates any effects of cardiopul- 
monary bypass, which may have a dramatic impact 
on the sensitivity and reactivity of the pulmonary 
vasculature in the postoperative period. 1° In many 
ways the model more accurately reflects the physi- 
ologic condition observed in patients with pulmo- 
nary atresia and intact ventricular septum who are 
dependent on a patent ductus arteriosus. However, 
this work focuses on the importance of monitoring 
mixed venous oxygen saturation, arteriovenous oxy- 
gen difference, and on the concept hat diminishing 
Qp/Qs is not always associated with improved oxy- 
gen delivery. This is ultimately the objective of our 
therapeutic maneuvers. 
Reddy and colleagues 6 address the limitations 
of the late postnatal animal model by creating an 
in utero model of single ventricle physiology. A 
Damus-Kaye-Stansel procedure was performed in 
fetal lambs and a systemic-pulmonary rtery shunt 
was created. The fetus was then allowed to develop 
and be delivered spontaneously at term. After birth, 
the pulmonary and systemic hemodynamic response 
to interventions were measured irectly, both before 
and after the lamb was supported by cardiopulmo- 
nary bypass and deep hypothermic irculatory ar- 
rest. The results support the clinical practice of 
manipulating PVR by altering the alveolar concen- 
tration of simple gases. Hypoxic gas mixtures and 
respiratory acidosis were potent pulmonary vaso- 
constrictors that redirected cardiac output away 
from the pulmonary bed and into the systemic 
circulation. Nitric oxide and high Fio 2 were pulmo- 
nary vasodilators. In this model, the respiratory 
acidosis derived from breathing 5% carbon dioxide 
(carbon dioxide tension 55 mm Hg, pH 7.25) im- 
posed marked changes in pulmonary vascular esis- 
tance and Qp/Qs. 
The work by Reddy and associates 6 represents 
remarkable technical accomplishment. It provides a 
physiologically relevant animal model of single ven- 
tricle physiology that can account for the transi- 
tional physiology of the newborn infant and the 
effects of cardiopulmonary b pass. Again, the model 
is not strictly characteristic of single ventricle anat- 
omy or physiology. Although there is common mix- 
ing of systemic and pulmonary venous blood, both 
right and left ventricles freely eject into the aorta 
where mixing occurs and from which the shunt- 
dependent pulmonary circulation is derived. Inas- 
much as the animal displays low, not high, PVR, it is 
not the most relevant physiologic model to investi- 
gate pulmonary vasodilators. However, if after fetal 
surgery and birth the animal model can be main- 
tained for some weeks and develop more of the 
pathologic features of elevated PVR, then it will 
provide an even more important investigational tool 
to study the influence of vasodilators on PVR before 
and after cardiopulmonary b pass. 
Manipulating gases 
Studies of Reddy and coworkers along with Rior- 
dan and associates corroborate the clinical practice 
of manipulating simple alveolar gases to achieve 
optimal balance between pulmonary and systemic 
vascular esistance in patients with complex single 
ventricles. Alveolar hypoxia, respiratory acidosis, 
and positive end-expiratory pressure raise PVR and 
can be used to advantage to optimize oxygen deliv- 
ery. Oxygen and nitric oxide relax the constricted 
pulmonary vasculature and may augment pulmo- 
nary blood flow. The appropriate use of animal 
models of single ventricle physiology will allow us to 
pose and accurately test hypotheses. A number of 
relevant questions come to mind. Is there any 
hemodynamic advantage in allowing carbon dioxide 
to be inspired while maintaining a high minute 
ventilation strategy? Is the simpler alternative, to 
diminish the minute ventilation and allow Paco 2 to 
rise, equally effective? Both animal and human 
infant studies after cardiopulmonary b pass indicate 
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that it is pH and not Paco 2 that is the primary 
determinant of pulmonary vascular esistance. 9 An- 
imal models will permit more precise testing of this 
principle in the setting of single ventricle physiology. 
The models also allow investigators to explore how 
vasoconstricting factors influence PVR after cardio- 
pulmonary bypass and what treatment is most effec- 
tive? 
Toxicity 
We must be cognizant hat like any therapeutic 
agent, all of these simple gases have dose-related 
toxicities. High Fio 2 has well-defined pulmonary 
toxicity that may appear in a matter of days or even 
hours after exposure. The use of low Fio 2 (below 
room air concentrations) to raise PVR transiently 
and stabilize patients is both counterintuitive and 
relatively uncommon therapy in clinical medicine. 
Whether iatrogenically induced or as part of a 
pathologic process, alveolar hypoxia can be life 
threatening when aggravated by unexpected hy- 
poventilation. A mechanically ventilated and se- 
dated patient receiving an Fio 2 less than 0.21 has 
little safety margin for dangerous hypoxemia even in 
the most intensively monitored environments. Also, 
recall that excellent animal models of long-term 
pulmonary hypertension are produced by relatively 
brief exposure to hypoxic gas. A newborn infant 
breathing hypoxic gas mixtures in the preoperative 
period of stabilization may have a favorable re- 
sponse by raising PVR and diminishing pulmonary 
blood flow. However, if this treatment is prolonged 
during preparation for reconstructive or transplan- 
tation surgery, the caretakers may be frustrated by 
subsequent elevation in PVR that persists during 
and after weaning from cardiopulmonary b pass. 
In centers where neonates are allowed to awaken 
and breath spontaneously during the immediate 
postoperative period, pulmonary blood flow may 
become excessive and will further stimulate hyper- 
ventilation and respiratory alkalosis. Adding carbon 
dioxide to the inspired gas may indeed reverse this 
trend toward respiratory alkalosis and stabilize the 
relative balance of the pulmonary and systemic 
circulations if the forces that drive minute ventila- 
tion are suppressed with agents for sedation or 
analgesia. However, the metabolic ost of carbon 
dioxide breathing in an awakening child given little 
analgesia, may discourage widespread application of 
this technique until the physiologic advantage over 
conventional means of controlling alveolar ventila- 
tion and Paco 2 has been demonstrated. This is 
especially true in unsedated, preoperative patients, 
in whom factors controlling respiration during car- 
bon dioxide breathing may permit minimal change 
of Paco 2 but substantially increase the respiratory 
rate and work of breathing. Inhaled nitric oxide may 
also have toxicitities, especially when used at higher 
doses. Methemoglobinemia, pulmonary toxicity re- 
lated to nitrogen dioxide exposure, and formation of 
peroxynitrite in the lung require further investigation. 
The simplicity of these ubiquitous gases is deceiv- 
ing when applied to complex pathophysiologic con- 
ditions of infants with single ventricles. The devel- 
opment of animal models can enhance our ability to 
investigate important questions and will focus atten- 
tion on more appropriate variables to monitor in the 
postoperative p riod. 
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